Trial intelligence / Profile preview

Gonal-f vs Puregon Pen in IVF/ICSI

NCT01081639Phase 3Completed

Sponsor
Merck KGaA
Start
Nov 2003
Primary completion
Sep 2004
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 3 trial of follitropin alfa in infertility, sponsored by Merck KGaA. Started Nov 2003; status: completed.

02

Drugs

follitropin alfa
03

Conditions

infertility

Beyond the preview

Go deeper on NCT01081639.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01081639.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call